Lars H. Jørgensen

770 total citations
30 papers, 565 citations indexed

About

Lars H. Jørgensen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Lars H. Jørgensen has authored 30 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 9 papers in Surgery and 9 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Lars H. Jørgensen's work include Lung Cancer Treatments and Mutations (9 papers), Thyroid Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Lars H. Jørgensen is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Thyroid Cancer Diagnosis and Treatment (8 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Lars H. Jørgensen collaborates with scholars based in Norway, Germany and France. Lars H. Jørgensen's co-authors include Krystyna Grøholt, Eva Sigstad, Trine Bjøro, Odd Terje Brustugun, Åslaug Helland, Steinar Solberg, Arne Heilo, Aasmund Berner, Ann Rita Halvorsen and Maria Moksnes Bjaanæs and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and International Journal of Cancer.

In The Last Decade

Lars H. Jørgensen

30 papers receiving 558 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars H. Jørgensen Norway 14 234 177 174 162 129 30 565
Sylwia Szpak‐Ulczok Poland 14 358 1.5× 255 1.4× 112 0.6× 130 0.8× 74 0.6× 28 645
Jingqiang Zhu China 17 507 2.2× 158 0.9× 316 1.8× 142 0.9× 55 0.4× 47 740
Ann W. Gramza United States 10 206 0.9× 137 0.8× 72 0.4× 52 0.3× 181 1.4× 22 552
Narihiko Kakoi Japan 10 191 0.8× 142 0.8× 254 1.5× 185 1.1× 138 1.1× 22 519
Kanchan Puttaswamy United States 7 472 2.0× 197 1.1× 90 0.5× 69 0.4× 94 0.7× 10 718
Juliette Haudebourg France 14 112 0.5× 144 0.8× 208 1.2× 119 0.7× 268 2.1× 37 651
Jianxin Shi China 16 59 0.3× 176 1.0× 150 0.9× 144 0.9× 186 1.4× 33 571
S. Hescot France 15 233 1.0× 54 0.3× 285 1.6× 222 1.4× 107 0.8× 48 604
Jill K. Burton United States 9 429 1.8× 136 0.8× 106 0.6× 79 0.5× 155 1.2× 14 677
Marilyn Mulay United States 11 134 0.6× 243 1.4× 71 0.4× 104 0.6× 250 1.9× 17 644

Countries citing papers authored by Lars H. Jørgensen

Since Specialization
Citations

This map shows the geographic impact of Lars H. Jørgensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars H. Jørgensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars H. Jørgensen more than expected).

Fields of papers citing papers by Lars H. Jørgensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars H. Jørgensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars H. Jørgensen. The network helps show where Lars H. Jørgensen may publish in the future.

Co-authorship network of co-authors of Lars H. Jørgensen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars H. Jørgensen. A scholar is included among the top collaborators of Lars H. Jørgensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars H. Jørgensen. Lars H. Jørgensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bjaanæs, Maria Moksnes, Gro Nilsen, Ann Rita Halvorsen, et al.. (2021). Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors. BMC Cancer. 21(1). 1089–1089. 6 indexed citations
2.
Halvorsen, Ann Rita, Mads H. Haugen, Marius Lund‐Iversen, et al.. (2020). Protein Kinase C Isozymes Associated With Relapse Free Survival in Non-Small Cell Lung Cancer Patients. Frontiers in Oncology. 10. 590755–590755. 4 indexed citations
3.
Akslen, Lars A., Ellen Schlichting, Turid Aas, et al.. (2019). The Role of Calcitonin in Predicting the Extent of Surgery in Medullary Thyroid Carcinoma: A Nationwide Population-Based Study in Norway. European Thyroid Journal. 8(3). 159–166. 29 indexed citations
4.
Akslen, Lars A., Ellen Schlichting, Turid Aas, et al.. (2018). Trends in Diagnostics, Surgical Treatment, and Prognostic Factors for Outcomes in Medullary Thyroid Carcinoma in Norway: A Nationwide Population-Based Study. European Thyroid Journal. 8(1). 31–40. 32 indexed citations
5.
Ekman, Simon, Maria Planck, Odd Terje Brustugun, et al.. (2017). MA 18.14 Non-Small Cell Lung Cancer (NSCLC) Treatment and Survival in Scandinavia: The SCAN-LEAF Study. Journal of Thoracic Oncology. 12(11). S1881–S1882. 1 indexed citations
6.
Brauckhoff, Michael, Ellen Schlichting, Johan Svartberg, et al.. (2016). A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Thyroid. 26(9). 1225–1238. 24 indexed citations
7.
Boye, Kjetil, Øystein Fodstad, Siri Juell, et al.. (2016). Detection of disseminated tumor cells in lymph nodes from patients with early stage non-small cell lung cancer. Diagnostic Pathology. 11(1). 50–50. 9 indexed citations
8.
Halvorsen, Ann Rita, Maria Moksnes Bjaanæs, Ruth Holm, et al.. (2016). The MYCN-HMGA2-CDKN2A pathway in non-small cell lung carcinoma—differences in histological subtypes. BMC Cancer. 16(1). 71–71. 13 indexed citations
9.
Ohnstad, Hege O., Øyvind S. Bruland, Ingeborg Taksdal, et al.. (2014). Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma – a predictor of outcome?. Acta Oncologica. 53(9). 1180–1187. 14 indexed citations
10.
Nordgård, Oddmund, Steinar Solberg, Lars H. Jørgensen, et al.. (2013). Novel Molecular Tumor Cell Markers in Regional Lymph Nodes and Blood Samples from Patients Undergoing Surgery for Non-Small Cell Lung Cancer. PLoS ONE. 8(5). e62153–e62153. 13 indexed citations
11.
Celestino, Ricardo, Eva Sigstad, Marthe Løvf, et al.. (2012). Survey of 548 oncogenic fusion transcripts in thyroid tumors supports the importance of the already established thyroid fusions genes. Genes Chromosomes and Cancer. 51(12). 1154–1164. 15 indexed citations
12.
Helland, Åslaug, Lilach Kleinberg, Thomas Fleischer, et al.. (2011). EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery. Journal of Thoracic Oncology. 6(5). 947–950. 39 indexed citations
13.
Sigstad, Eva, Elisabeth Paus, Trine Bjøro, et al.. (2011). The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors. Modern Pathology. 25(4). 537–547. 13 indexed citations
14.
Sigstad, Eva, Arne Heilo, Elisabeth Paus, et al.. (2007). The usefulness of detecting thyroglobulin in fine‐needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay. Diagnostic Cytopathology. 35(12). 761–767. 58 indexed citations
15.
16.
Jørgensen, Lars H., E Thaulow, & H. E. Refsum. (1996). Hemodynamic time course of acute and chronic isosorbide dinitrate treatment at rest and during exercise in patients with stable ischemic heart disease. Clinical Cardiology. 19(9). 718–724. 2 indexed citations
17.
Jørgensen, Lars H., Erik Thaulow, & H. E. Refsum. (1995). Early hemodynamic effects at rest with acute and chronic isosorbide dinitrate treatment in patients with ischemic heart disease. Clinical Cardiology. 18(8). 455–459. 1 indexed citations
18.
Jørgensen, Lars H., H. E. Refsum, & Erik Thaulow. (1994). Influence of glyceryl trinitrate on venous and arterial effects of chronic, asymmetric isosorbide dinitrate treatment in patients with ischemic heart disease. Clinical Cardiology. 17(2). 65–70. 4 indexed citations
19.
Lyberg, Torstein, et al.. (1993). Location of plasminogen activator (PA) and PA inhibitor in human colorectal adenocarcinomas. Apmis. 101(1-6). 235–241. 33 indexed citations
20.
Tveter, Kjell J., et al.. (1993). Total Androgen Suppression:Experience from theScandinavian Prostatic CancerGroup Study No. 2. European Urology. 24(4). 466–470. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sylwia Szpak‐Ulczok Breakdown of academic impact, for papers by Jingqiang Zhu Breakdown of academic impact, for papers by Ann W. Gramza Breakdown of academic impact, for papers by Narihiko Kakoi Breakdown of academic impact, for papers by Kanchan Puttaswamy Breakdown of academic impact, for papers by Juliette Haudebourg Breakdown of academic impact, for papers by Jianxin Shi Breakdown of academic impact, for papers by S. Hescot Breakdown of academic impact, for papers by Jill K. Burton Breakdown of academic impact, for papers by Marilyn Mulay
Rankless by CCL
2026